InvestorsHub Logo
Followers 99
Posts 5356
Boards Moderated 0
Alias Born 08/27/2011

Re: None

Thursday, 12/08/2011 6:22:12 PM

Thursday, December 08, 2011 6:22:12 PM

Post# of 27557
ASM synopsis
Mr Erwin did not attend I spoke with him night before meeting and he said he had to fly out for a client that called and wanted to finalize a contract today of all days overseas.
Monoclonal Antibody produced next is Humira!
Fiocruz has ordered additional Launch platforms.
IBIO Launch expression platform produced antineuramidase monoclonal antibody which is active against "Tamiflu" resistant virus strains.
No talk of buyout Its not for sale now per Kay.
IBIO Launch does not produce endogenous viruses is nontransgenic.
No protein glycosylation which can cause allergic reaction.
IBIO Launch is the fastest most inexpesive expression system available to produce all biologics, monoclonal antibodies and vaccines, many of which have never been isolated.
IBIO will be going after HIV vaccine.
IBIOLaunch is "For Sale lic TODAY"
Expect to annouce 4 contracts 1st qtr of 2012
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IBIO News